Join Mission Bio and Synthego for an engaging webinar exploring the revolutionary potential of CRISPR genome editing. CRISPR has ushered in a new era of research and precision medicine, offering targeted modifications in genetic sequences. However, the power of CRISPR comes with a complex challenge– edits often yield heterogeneous outcomes.
In this session, we’ll delve into the intricacies of CRISPR editing and dissect the heterogeneity of editing outcomes and their implications. We will explore the cutting edge in cell engineering, including automated gene editing on Synthego’s Eclipse platform to generate reproducible results and multi-guide RNA approaches for high efficiency knockouts. Mission Bio will introduce a transformative single-cell assay for measuring CRISPR outcomes to dissect zygosity, co-occurrence, and off-target edits.
Join our CRISPR and single-cell experts to uncover insights and best practices for maximizing the power of CRISPR while addressing the complexities of its varied editing outcomes. Whether you’re a seasoned researcher or new to the field, this webinar promises to illuminate the intricate facets of CRISPR genome editing and its impact on research and therapy.